Klaas Financial Asset Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-521
Closed -$45K 65
2022
Q3
$45K Hold
521
0.01% 52
2022
Q2
$48K Hold
521
0.01% 51
2022
Q1
$43K Buy
521
+4
+0.8% +$315 0.01% 52
2021
Q4
$40K Buy
517
+5
+1% +$398 0.01% 56
2021
Q3
$38K Buy
512
+4
+0.8% +$304 0.01% 55
2021
Q2
$40K Sell
508
-20
-4% -$1.49K 0.01% 54
2021
Q1
$39K Sell
528
-35
-6% -$2.58K 0.01% 45
2020
Q4
$44K Buy
+563
New +$43.1K 0.01% 42

Other funds holding MRK

Klaas Financial Asset Advisors's MRK Position: Q4 2022 in Review

Klaas Financial Asset Advisors sold out of Merck (MRK) in Q4 2022, closing a stake of 521 shares — an estimated $45K sold.

Klaas Financial Asset Advisors first reported a position in MRK in Q4 2020 and held it in 8 quarters. The position peaked at $48K in Q2 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Klaas Financial Asset Advisors reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Klaas Financial Asset Advisors sold 521 Merck shares in Q4 2022, an estimated $45K.
  • Klaas Financial Asset Advisors first reported a position in Merck in Q4 2020 and held it in 8 quarters.
  • Klaas Financial Asset Advisors's Merck position peaked at $48K in Q2 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Klaas Financial Asset Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.